课题基金 / 基金详情

EFFECTS OF GLYCOL ETHERS ON BONE MARROW PARAMETERS

EFFECTS OF GLYCOL ETHERS ON BONE MARROW PARAMETERS
乙二醇醚对骨髓参数的影响
批准号:
3898086
负责人:
H L HONG
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

H L HONG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Ethylene glycol (EG) or ethylene glycol monomethyl ether (EGMME) was administered by gavage to both sexes of B6C3F1 mice for 4 consecutive days at total doses of 200,400, and 1000 mg/kg body weight. Bone marrow parameters were examined on days 1,5, and 14 after their final treatment. Exposure to EG produced hypocellularity and suppression of granulocyte- macrophage progenitor (CFU-C) colony formation in both sexes on days 1 and 5 postexposure. Values returned to normal by day 14 in the female mice but not in the males. Erythropoiesis, as measured by 59 Fe incorporation and quantitation of erythroid precursors in culture (CFU- E), revealed no effect in female mice and affected male mice at the high dose only. In contrast, EGMME exposure in female mice resulted in inhibition of erythropoiesis. There was also a pronounced effect on white blood cells with decreased peripheral counts, and decreases in the number of CFU-C's cultured from marrow cells. The effect of EGMME was also seen at the lower dose levels and was sustained through the 14-day evaluation period. In addition, EGMME caused a 20% decrease in testicular weight, which was shown microscopically to be a segmented degeneration of seminiferous tubules, an effect not found with EG. This study demonstrates that EGMME is more myelotoxic in mice than EG and that pancytopenia is more pronounced in males, while erythropoiesis is more affected in females. These results were published in J. Environ. Path. Toxicol. Oncol,.8 (7) p. 27-38, 1988.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RAS ONCOGENE MUTATIONS IN LIVER NEOPLASMS OF B6C3F1 MICE ESPOSED TO TFE
EFFECTS OF GLYCOL ETHERS ON BONE MARROW PARAMETERS
EFFECTS OF GLYCOL ETHERS ON BONE MARROW PARAMETERS
EFFECTS OF D-LIMONENE ON ALPHA 2U-GLOBULIN IN RAT KIDNEY
海外基金